15. Assisted Conception

Medical Law ◽  
2019 ◽  
pp. 792-860
Author(s):  
Emily Jackson
Keyword(s):  
Genome Editing ◽  
Preimplantation Genetic Diagnosis ◽  
Genetic Diagnosis ◽  
Gamete Donation ◽  
Assisted Conception ◽  
Access To Treatment ◽  
Human Fertilisation ◽  
Mitochondrial Transfer ◽  
The Uk ◽  
Academic Debate

All books in this flagship series contain carefully selected substantial extracts from key cases, legislation, and academic debate, providing students with a stand-alone resource. This chapter discusses the regulation of assisted conception. It first examines the regulation of assisted conception in the UK, which involves a detailed look at the legislation: the Human Fertilisation and Embryology Act 1990, and the work of the Human Fertilisation and Embryology Authority (HFEA). The chapter analyses: the licensing procedures through which clinics are inspected and authorized to perform certain procedures; access to treatment; consent to the use of gametes (sperm and eggs); gamete donation; rules governing the parentage of children; and preimplantation genetic diagnosis (PGD). It also considers mitochondrial transfer and genome editing.

Reprogenetic Technologies

2016 ◽  
Author(s):  
Inmaculada de Melo-Martín
Keyword(s):  
In Vitro Fertilization ◽  
Preimplantation Genetic Diagnosis ◽  
Gene Editing ◽  
Genetic Diagnosis ◽  
Vitro Fertilization ◽  
Technological Advances ◽  
Mitochondrial Transfer

This chapter offers a brief description of the main reprogenetic technologies in use today as well as some of the most significant ones being developed. Because of their relevance in the field, particular attention is given to in vitro fertilization (IVF) and preimplantation genetic diagnosis (PGD). The chapter discusses the differences between somatic and germline modifications, the most common uses of reprogenetic technologies today, and some possible and likely future uses. It also includes a description of recent technological advances such as mitochondrial transfer and gene editing techniques.

Preimplantation genetic diagnosis for myotonic dystrophy type 1 in the UK

2008 ◽  
Vol 18 (2) ◽  
pp. 131-136 ◽  
Author(s):  
Georgia Kakourou ◽  
Seema Dhanjal ◽  
Thalia Mamas ◽  
Sarah Gotts ◽  
Alpesh Doshi ◽  
...  
Keyword(s):  
Myotonic Dystrophy ◽  
Preimplantation Genetic Diagnosis ◽  
Genetic Diagnosis ◽  
Myotonic Dystrophy Type 1 ◽  
Myotonic Dystrophy Type ◽  
The Uk

Facilitating choice, framing choice: Staff views on widening the scope of preimplantation genetic diagnosis in the UK

2007 ◽  
Vol 65 (6) ◽  
pp. 1094-1105 ◽  
Author(s):  
Clare Williams ◽  
Kathryn Ehrich ◽  
Bobbie Farsides ◽  
Rosamund Scott
Keyword(s):  
Preimplantation Genetic Diagnosis ◽  
Genetic Diagnosis ◽  
Choice Framing ◽  
The Uk

The Legalisation of Gamete Donation in Italy

2017 ◽  
Vol 24 (1) ◽  
pp. 85-104
Author(s):  
Andrea Boggio
Keyword(s):  
Preimplantation Genetic Diagnosis ◽  
Assisted Reproduction ◽  
Reproductive Rights ◽  
Genetic Diagnosis ◽  
Embryo Selection ◽  
Gamete Donation ◽  
Embryo Production ◽  
Limited Access ◽  
Assisted Reproduction Technologies ◽  
Judicial Intervention

Since 2004, the regulation of assisted reproduction in Italy has undergone substantial reform as an effect of key judicial intervention. Limitations on embryo production, screening and transfer, the prohibition against engaging in preimplantation genetic diagnosis (pgd) and embryo selection, and the ban on gamete donation have all been removed by courts. In this article, I discuss how judicial intervention has improved the ability of Italian couples to access assisted reproduction technologies (arts), and how the expansion of reproductive rights is, however, still incomplete. In particular, I discuss the challenges in implementing the liberalisation of gamete donation, and identify the practical, political and cultural reasons for limited access to gamete donation. I also discuss the future of the prohibitions and restrictions that still exist in Law 40/2004.

The regulation of preimplantation genetic diagnosis (PGD) in the Netherlands and the UK: a comparative study of the regulatory frameworks and outcomes for PGD

2008 ◽  
Vol 3 (4) ◽  
pp. 176-179 ◽  
Author(s):  
Eva C A Asscher
Keyword(s):  
Preimplantation Genetic Diagnosis ◽  
New Technologies ◽  
Genetic Diagnosis ◽  
The European Union ◽  
Political Systems ◽  
Ethical Challenges ◽  
New Developments ◽  
Regulatory Frameworks ◽  
The Uk ◽  
Selection Of

Developments in biotechnology present difficult social and ethical challenges that need to be resolved by regulators among others. One crucial problem for regulators of new technologies is to ensure that regulation is both clear and sufficiently flexible to respond to new developments. This is particularly difficult to achieve in contentious fields such as medical biotechnology. In the European Union there is a divergence in the solutions to this problem which has lead to different regulatory frameworks for medical biotechnology. This paper compares and contrasts the British and Dutch regulatory frameworks for the selection of embryos by preimplantation genetic diagnosis as an example of the regulation of medical biotechnology. Some of the outcomes of the regulatory choices and possible reasons behind the divergent frameworks are discussed, such as the ethical outlooks and political systems in these countries.

Sign in / Sign up

Export Citation Format

Share Document